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As of 12/01/2007, 36 kidney Ts took place at our center since the rule change and 
were compared to the 36 sequential Ts preceding the rule change. There were no 
statistically significant differences in recipients mean age (12 vs. 14 years), gender (61 
vs. 64% male), or ethnicity (67 vs. 75% Caucasian) before vs. after the rule change. 
Moreover, the percentage of pre-emptive Ts and re-Ts were identical in both groups 
(27.8 and 16.7%, respectively), and the percentage of patients with high (>10%) peak 
panel-reactive antibodies was not significantly different (19.5% before vs. 27.8% after). 
There was a significant difference in mean donor age (32.4 years before vs. 22.8 years 
after, p = 0.002). Patient survival (100% in both groups) and 1-year graft survival were 
comparable (100% before vs. 90% after, p = 0.06). Significant increases were found 
in the percentage of deceased donor (DD) Ts and HLA mismatches (MMs) after the 
rule change (14% DDs before vs. 57% DDs after, p = 0.002; 2.8 MMs before vs. 3.6 
MMs after, p = 0.03). We next compared the mean wait time for DD kidneys in the 
20 DD Ts since the rule change with the wait time of the most recent 20 DD kidney 
recipients before the rule change and found that recipients under the age of 18 years 
had a significantly longer wait time before the rule change (315 vs. 119 days, p = 0.04). 
Mean donor age in these 2 DD T cohorts was not significantly different (15.3 years 
before vs. 18.4 years after).
We conclude that at our center, the current allocation rules are associated with a 
substantial decrease in wait time for DD Ts and an increase in their relative number. 
Overall HLA matching decreased, but there was no statistically significant worsening 
in short-term patient or graft survival. These data suggest that overall access to kidney 
transplantation has improved for children. However, the accompanying decreases in LD 
Ts and HLA matching may affect long-term outcomes and possibly the overall donor 
pool unfavorably. Larger studies are needed to evaluate these possibilities.
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Until a few years ago, HIV infection was considered an exclusion criteria for organ 
transplantation. However, more recently, because of the significant increase in life 
expectancy of HIV-infected persons with highly active antiretroviral therapy (HAART), 
kidney, kidney-pancreas, heart, lung and liver transplantation have been introduced in 
this patients population in several centers around the world. To evaluate the possible 
extension of the indications of kidney transplantation to HIV-infected individuals, the 
Italian National Centre for Transplantation has designed a protocol to be applied on a 
national basis. Inclusion criteria required a CD4 count ≥200/mm3 and undetectable HIV 
viral load for at least 3 months for patients on HAART.The program was voluntarily 
adopted by 4 transplant centres. From January 2006 through November 2007 a total 
of 13 HIV infected patients (9 male and 4 female, mean age 46.4 years, range 35-56) 
underwent cadaveric kidney transplantation (including two kidney-pancreas and two 
liver-kidney) after a median waiting time of 142 days (range 58-650). Median CD4 cells 
count at the time of transplantation was 449 (range 210-782) and the HIV-RNA was 
undetectable in all recipients. HAART was started in all recipients after transplantation 
and HIV-RNA remain undetectable in all patients. Five patients (38.4%) experienced 
an episode of biopsy proven acute rejection (steroid resistant in one). Drug-drug 
interactions between antiretrovirals and immunosuppressive agents required frequent 
dosage modifications. Graft and patient survival was 100% at a median follow-up of 
161 days after transplantation (range 8-669). Despite the limited number of patients 
and the shortness of the follow-up, our study confirms excellent short term results of 
kidney transplantation in HIV-infected individuals.
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Expanded criteria allografts exhibit a striking reduction in 5-year graft survival. 
We evaluated glomerular function and number in 43 subjects, who were studied 
perioperatively. ECD allograft recipients >55 yrs of age (59 ±5 yr, n=20) were examined 
and youthful deceased donors aged 18-40 yrs served as controls (24 ±6 yr, n=23). 
All recipients had a wedge biopsy at transplantation. Glomeruli were subjected to a 
morphometric analysis and computation of a single nephron ultrafiltration coefficient 
(SNKf). All but 6 patients had evaluation of GFR and its determinants 1-5 months 
post-Tx after SCr had reached a stable, nadir level (1.2 ±0.3 in aging vs 1.0 ±0.3 in 
youthful, p=0.03). GFR, renal plasma flow and oncotic pressure were determined by 
standard methods. The allograft ultrafiltration coefficient (Kf) was calculated by the 
model of Deen et. al. GFR at follow-up was lower in the aging than the youthful group 
by 30% (48 ±21 vs 69 ±17 ml/min, p=0.001). Neither MAP nor plasma oncotic pressure 
differed between the groups. The computed value for Kf in recipients of ECD was 
depressed 44% below youthful donors (3.7 ±2.2 vs 6.6 ±3.4 ml/min·mmHg; p<0.001). 
Thus, the extent of GFR depression seen in the aging donor group can entirely be 
accounted for by a decrease in Kf alone. Light and morphometric analysis revealed the 
%glomerulosclerosis to be higher in the aging (17 ±11% vs 2 ±2%, p=0.002), which 
fails to account for the difference in allograft Kf or GFR. Enlarged glomerular volume 
and surface area resulted in a higher SNKf in the aging group (11.1 ±3.5 vs 8.6 ±2.6 
nl/min·mmHg, p=0.07) and is consistent with glomerulopenia, but fails to account for 
the low Kf. Dividing Kf by SNKf provides an estimate of the number of functioning 
glomeruli, which was profoundly depressed in the aging compared to the youthful group 
(355 ±211 vs 847±344 x 106, p<0.05; fig 1).
We conclude that accelerated renal senescence in ECD results in glomerulopenia. Those 
subjects in the bottom quartile receiving a single allograft would have less than 15% of 
the normal complement of glomeruli and could lead to the remnant kidney phenomenon 
with progressive allograft failure.
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Renal transplantation has become increasingly prevalent in the geriatric population 
accounting for 13.2% renal transplants performed nationally. We reviewed 3297 renal 
transplant recipients from our transplant database over the last 15 years to evaluate 
outcomes in the geriatric population. We used Kaplan-Meier survival estimates and 
logrank estimates of statistical significance. Our center has performed 468 living 
(LDRTx) and deceased donor renal transplants (DDRTx) in patients over the age of 
65 years old since 1991. We have performed 14.2% of all renal transplants in patients 
over the age of 65 years old, 5.7% of transplants in patients over 70 years old, and 1.8% 
(60 transplants) in patients over 75 years old. Geriatric recipients (over 65 years old) 
of DDRTx demonstrated 83.0%, 74.1%, and 64.1% graft survivals at 1, 3, and 5 years. 
Geriatric DDRTx recipients had overall equal graft survivals to adult DDRTx (p=0.49). 
Geriatric recipients of LDRTx demonstrated 1 year graft survival of 94.3%, 3 year graft 
survival of 88.8%, and 5 year graft survival of 72.3%. These results were better than 
geriatric DDRTx recipients (p=0.04), but not as good as graft survival in adult (18-64 
years old) LDRTx recipients (p=0.006). This was predominantly driven by poorer graft 
survival in LDRTx recipients older than 75 years (p=0.004). Graft survival in geriatric 
LDRTx recipients 65-69 years old (p=0.04) and 70-74 years old (p=0.4) had more 
equivalent outcomes to adult LDRTx recipients. These data support the good outcomes 
of both LDRTx and DDRTx in the geriatric population. DDRTx geriatric recipients had 
similar graft survivals to adult DDRTx recipients. LDRTx geriatric recipients had better 
outcomes than geriatric DDRTx recipients; although, not equal to the excellent results 
of younger LDRTx recipients.
